DaVita Inc. (DVA) reported third quarter net income of $110.9 million or $1.06 per share, which was better than the Zacks Consensus Estimate of 99 cents. The company earned $93.9 million or 89 cents in the comparable quarter of 2008.  Revenues for the quarter came in at $1.57 billion, which reflected an 8.3% increase over the year-ago quarter. According to segments, revenues from the Dialysis and Related Lab Services segment for the quarter came in at $1.49 billion as against $1.38 billion in the prior-year quarter. Other - Ancillary Services and Strategic Initiatives segment generated revenues of $83 million as against $69 million in the year-ago quarter. Highlights of the strong display in the reported quarter included consistent volume growth, stable private pricing and strong cash flows.  Total treatments for the quarter came in at approximately 4.34 million, or 54,927 treatments per day, representing a per ...

DaVita Inc.’s (DVA) share price has entered into oversold territory with a stochastic value of 17.17. Analysts have been increasing their estimates on the company’s full-year earnings, sending the Zacks Consensus Estimate up by a penny over the past month to $3.95 per share. DaVita is a Zacks #2 Rank (“Buy") company."DVA" Free Stock Analysis: Buy? Sell? Hold?Zacks Investment Research

After market close yesterday, DaVita Inc. (DVA) reported second quarter net income of $105.8 million or $1.02 per share, which was better than the Zacks Consensus Estimate of 95 cents. The company reported a net income of $95.0 million or 90 cents per share in the comparable quarter of 2008.   Net operating revenues for the quarter were $1.52 billion, which reflected an 8% increase over the year-ago quarter. Highlights of the strong display in the reported quarter included consistent volume growth, stable private pricing and strong cash flows. Total treatments for the quarter were 4,228,179, or 54,207 treatments per day, representing a per day increase of 5.2% over the year-ago quarter. Non-acquired treatment growth in the quarter was 4.5% over the prior year's second quarter. The company expects non-acquired growth to be around 4% for the year. The largest provider of dialysis services to patients ...

PennyOmega.com Stock Report!

PennyOmega.com Hot Stock News & Alerts!

 

Tuesday July 28, 2009

PennyOmega.com Stock Report!

**************************************************************

Signature Bank (Nasdaq: SBNY), a New York-based full-service commercial bank, today announced results for its 2009 second quarter ended June 30, 2009. Net income for the 2009 second quarter reached $12.0 million, or $0.32 diluted earnings per share, compared with $10.9 million, or $0.36 diluted earnings per share, for the 2008 second quarter. Excluding the after tax effect of the FDIC Special Assessment of $3.5 million, net income for the quarter was $13.9 million, or $0.38 diluted earnings per share, an increase of 28.5 percent.

Bristol-Myers Squibb Company (NYSE:BMY) is commencing today, through its wholly owned subsidiary Puma Acquisition Corporation,

...

Today we are featuring top-performing "growth equity" mutual funds that primarily seek to provide long-term growth through investment in common stocks.

Investors can find such funds by checking out the entire list of the Zacks #1 Rank Growth Equity Funds.

3 Outstanding Examples 

Oppenheimer Absolute Return A (OARAX) seeks capital appreciation. The fund primarily invests in common stocks of U.S. and foreign companies.

Although it may invest without limit in any country, including developed or emerging markets, the fund currently focuses on developed markets of the US, Western Europe and Japan.

Unit holders have to make a minimum initial investment of $1,000 to enter the fund. This Zacks #1 Rank ("Strong Buy") fund has an expense ratio of 1.32%. OARAX distributes dividends annually.

Highland Long/Short Equity A (HEOAX) seeks consistent, above-average total returns primarily through capital appreciation, while

...

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

Aaron Rents Inc (RNT) Air Liquide (AIQUY) American Caresource Holdings Inc (ANCI) Analogic Corp (ALOG) ARCA Biopharma Inc (ABIO) Corcept Therapeutics Inc (CORT) DaVita Inc (DVA) Dendreon Corp (DNDN) Dolan Media Co (DM) Centrais Eletricas Brasileiras SA - Eletrobras (EBR.B) Gander Mountain Co (GMTN) Grupo Financiero Galicia SA (GGAL) Hansen Natural Corp (HANS) Jazz Pharmaceuticals Inc (JAZZ) Jos A Bank Clothiers Inc (JOSB) Local.com Corp (LOCM) Magellan Health Services Inc (MGLN) Matrixx Initiatives Inc (MTXX) The Navigators Group Inc (NAVG) Ocean Power Technologies Inc (OPTT) Prudential Public Limited Co (PUK) Stamps.com Inc (STMP) TreeHouse Foods Inc (THS) Varian Medical Systems Inc (VAR) World Acceptance Corp (WRLD) View the entire ...

DaVita Inc (DVA) shares are experiencing unusually high trading volume. The El Segundo-based company's stock plunged over 5% since the morning trade.

Zacks Investment Research

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

Aaron Rents Inc (RNT) Alliance One International Inc (AOI) BioReference Laboratories Inc (BRLI) Claude Resources Inc (CGR) Corus Entertainment Inc (CJR) DaVita Inc (DVA) DepoMed Inc (DEPO) Gammon Gold Inc (GRS) Jarden Corp (JAH) ManTech International Corp (MANT) Orexigen Therapeutics Inc (OREX) Pennichuck Corp (PNNW) PokerTek Inc (PTEK) Radio One Inc (ROIAK) ResMed Inc (RMD) South Jersey Industries (SJI) Tucows Inc (TCX) View the entire Zacks #1 Rank List.

Zacks Investment Research

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

Aaron Rents Inc (RNT) Access National Corp (ANCX) Allied World Assurance Holdings Ltd (AWH) Atlantic Tele-Network Inc (ATNI) Compania de Minas Buenaventura SA (BVN) Corus Entertainment Inc (CJR) Culp Inc (CFI) Dassault Systemes SA (DASTY) DaVita Inc (DVA) DepoMed Inc (DEPO) EZCORP Inc (EZPW) Geron Corp (GERN) Grand Canyon Education Inc (LOPE) Grupo Financiero Galicia SA (GGAL) IPCS Inc (IPCS) Ivanhoe Mines Ltd (IVN) Lundin Mining Corp (LMC) Masimo Corp (MASI) Medivation Inc (MDVN) National Grid Plc (NGG) Noven Pharmaceuticals Inc (NOVN) Oncolytics Biotech Inc (ONCY) Orexigen Therapeutics Inc (OREX) Radvision Ltd (RVSN) Santarus Inc (SNTS) Taleo Corp (TLEO) View the entire Zacks #1 Rank List.

...

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

Aaron Rents Inc (RNT) Acxiom Corp (ACXM) Alliance One International Inc (AOI) Allied Capital Corp (ALD) American Equity Investment Life Holding (AEL) Anaren Inc (ANEN) Aqua America Inc (WTR) AsiaInfo Holdings Inc (ASIA) Broadridge Financial Solutions Inc (BR) Caribou Coffee Company Inc (CBOU) Carrols Restaurant Group Inc (TAST) Celldex Therapeutics Inc (CLDX) Chinacast Education Corp (CAST) Cosan Ltd (CZZ) DaVita Inc (DVA) Energy Recovery Inc (ERII) EZCORP Inc (EZPW) FPIC Insurance Group Inc (FPIC) General Mills Inc (GIS) Horsehead Holding Corp (ZINC) Immucor Inc (BLUD) Jarden Corp (JAH) Javelin Pharmaceuticals Inc (JAV) Magyar Telekom Plc (MTA) MAP Pharmaceuticals Inc (MAPP) Maxcom Telecomunic SAB de CV (MXT) Mercer Insurance Group ...